Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation or Flutter”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableActive Not RecruitingNCT05883631
What this trial is testing

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Who this might be right for
Atrial FibrillationAtrial Fibrillation, PersistentAtrial Fibrillation Paroxysmal+6 more
Cortex 400
Post-approval studies (Phase 4)Study completedNCT01914926
What this trial is testing

Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter

Who this might be right for
Heart Rate and Rhythm Disorders
Antonios Likourezos 54
Large-scale testing (Phase 3)Study completedNCT00174785
What this trial is testing

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationAtrial Flutter
Sanofi 4,628
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Post-approval studies (Phase 4)Study completedNCT01976507
What this trial is testing

Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism

Who this might be right for
Atrial FibrillationAtrial Flutter
Vanderbilt University Medical Center 101
Testing effectiveness (Phase 2)Study completedNCT01691313
What this trial is testing

Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm

Who this might be right for
Symptomatic Atrial FibrillationAtrial Flutter
Laguna Pharmaceuticals, Inc. 104
Not applicableUnknownNCT00315068
What this trial is testing

Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation

Who this might be right for
Atrial Fibrillation
University Hospital, Geneva 180
Post-approval studies (Phase 4)Looking for participantsNCT06402851
What this trial is testing

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Who this might be right for
Atrium; FibrillationChronic Kidney Diseases
Hospital Sirio-Libanes 1,500
Not applicableLooking for participantsNCT05724121
What this trial is testing

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Waldenstr(SqrRoot)(Delta)m s MacroglobulinemiaMantle Cell Lymphoma+3 more
National Heart, Lung, and Blood Institute (NHLBI) 135
Testing effectiveness (Phase 2)Study completedNCT01970501
What this trial is testing

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Who this might be right for
Current or Recent History of Atrial Fibrillation
ARCA Biopharma, Inc. 267
Large-scale testing (Phase 3)UnknownNCT00691470
What this trial is testing

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

Who this might be right for
Atrial FibrillationAtrial FlutterVenous Thromboembolic Disease+2 more
ARYx Therapeutics 600
Large-scale testing (Phase 3)Study completedNCT00125320
What this trial is testing

Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery

Who this might be right for
Atrial FibrillationAtrial Flutter
Astellas Pharma Inc 190
Large-scale testing (Phase 3)Study completedNCT00233441
What this trial is testing

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

Who this might be right for
Atrial FibrillationAtrial Flutter
Sanofi 673
Post-approval studies (Phase 4)Study completedNCT05661942
What this trial is testing

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Who this might be right for
Atrial Fibrillation With Rapid Ventricular ResponseHypotension Drug-Induced
Wake Forest University Health Sciences 92
Not applicableLooking for participantsNCT06876896
What this trial is testing

Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter

Who this might be right for
Intra-Abdominal Hypertension
Wake Forest University Health Sciences 50
Large-scale testing (Phase 3)Study completedNCT00126074
What this trial is testing

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Who this might be right for
Atrial FibrillationAtrial Flutter
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00126022
What this trial is testing

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Who this might be right for
Atrial FibrillationAtrial Flutter
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01839357
What this trial is testing

Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter

Who this might be right for
Atrial Fibrillation
Bayer 60
Large-scale testing (Phase 3)Study completedNCT00115791
What this trial is testing

Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

Who this might be right for
Atrial FlutterAtrial Fibrillation
Astellas Pharma Inc 276
Testing effectiveness (Phase 2)Study completedNCT00232310
What this trial is testing

Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr

Who this might be right for
Atrial FibrillationAtrial Flutter
Sanofi 150
Load More Results